Literature DB >> 15286396

Animal models of scleroderma.

Gabriella Lakos1, Shinsuke Takagawa, John Varga.   

Abstract

Although no single animal model of systemic sclerosis (SSc) faithfully reproduces all features of the human disease, certain animal models that display some of the features of SSc are potentially useful as they may be helpful in gaining a better understanding of the pathogenesis of SSc as well as developing novel therapeutic interventions. This chapter gives the detailed description of the two most useful animal models of SSc: bleomycin-induced skin fibrosis and the sclerodermatous graft-vs-host disease in mice. It provides the methodology of the induction as well as the repertoire of the different approaches that can be used to investigate the skin fibrosis in these models, including histopathology, immunohistochemistry, dermal thickness, hydroxyproline content of the skin, and analysis of dermal cells by flow cytometry.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286396     DOI: 10.1385/1-59259-805-6:377

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  10 in total

1.  The early growth response gene Egr2 (Alias Krox20) is a novel transcriptional target of transforming growth factor-β that is up-regulated in systemic sclerosis and mediates profibrotic responses.

Authors:  Feng Fang; Kohtaro Ooka; Swati Bhattacharyya; Swati Bhattachyya; Jun Wei; Minghua Wu; Pan Du; Simon Lin; Francesco Del Galdo; Carol A Feghali-Bostwick; John Varga
Journal:  Am J Pathol       Date:  2011-05       Impact factor: 4.307

2.  Prevention of excessive collagen accumulation by human intravenous immunoglobulin treatment in a murine model of bleomycin-induced scleroderma.

Authors:  M Kajii; C Suzuki; J Kashihara; F Kobayashi; Y Kubo; H Miyamoto; T Yuuki; T Yamamoto; T Nakae
Journal:  Clin Exp Immunol       Date:  2010-11-22       Impact factor: 4.330

Review 3.  Animal models in scleroderma.

Authors:  Stephen H Clark
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

4.  Early growth response 3 (Egr-3) is induced by transforming growth factor-β and regulates fibrogenic responses.

Authors:  Feng Fang; Anna J Shangguan; Kathleen Kelly; Jun Wei; Katherine Gruner; Boping Ye; Wenxia Wang; Swati Bhattacharyya; Monique E Hinchcliff; Warren G Tourtellotte; John Varga
Journal:  Am J Pathol       Date:  2013-07-30       Impact factor: 4.307

Review 5.  Is scleroderma a vasculopathy?

Authors:  Jo Nadine Fleming; Richard A Nash; William M Mahoney; Stephen Mark Schwartz
Journal:  Curr Rheumatol Rep       Date:  2009-04       Impact factor: 4.592

6.  Smad-independent transforming growth factor-beta regulation of early growth response-1 and sustained expression in fibrosis: implications for scleroderma.

Authors:  Swati Bhattacharyya; Shu-Jen Chen; Minghua Wu; Matthew Warner-Blankenship; Hongyan Ning; Gabriella Lakos; Yasuji Mori; Eric Chang; Chihiro Nihijima; Kazuhiro Takehara; Carol Feghali-Bostwick; John Varga
Journal:  Am J Pathol       Date:  2008-09-04       Impact factor: 4.307

7.  Adiponectin is an endogenous anti-fibrotic mediator and therapeutic target.

Authors:  Roberta G Marangoni; Yuri Masui; Feng Fang; Benjamin Korman; Gabriel Lord; Junghwa Lee; Katja Lakota; Jun Wei; Philipp E Scherer; Laszlo Otvos; Toshimasa Yamauchi; Naoto Kubota; Takashi Kadowaki; Yoshihide Asano; Shinichi Sato; Warren G Tourtellotte; John Varga
Journal:  Sci Rep       Date:  2017-06-30       Impact factor: 4.379

8.  Assessing the progression of systemic sclerosis by monitoring the tissue optic axis using PS-OCT.

Authors:  David C Adams; Margit V Szabari; David Lagares; Andrew F McCrossan; Lida P Hariri; Andrew M Tager; Melissa J Suter
Journal:  Sci Rep       Date:  2020-02-13       Impact factor: 4.379

Review 9.  Mesenchymal stem cell as a novel approach to systemic sclerosis; current status and future perspectives.

Authors:  Mina Abedi; Sepideh Alavi-Moghadam; Moloud Payab; Parisa Goodarzi; Fereshteh Mohamadi-Jahani; Forough Azam Sayahpour; Bagher Larijani; Babak Arjmand
Journal:  Cell Regen       Date:  2020-12-01

10.  Collagen V-induced nasal tolerance downregulates pulmonary collagen mRNA gene and TGF-beta expression in experimental systemic sclerosis.

Authors:  Ana Paula P Velosa; Walcy R Teodoro; Daniel M dos Anjos; Renata Konno; Cristiane C Oliveira; Maria L H Katayama; Edwin R Parra; Vera L Capelozzi; Natalino H Yoshinari
Journal:  Respir Res       Date:  2010-01-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.